Multiple Drug Recalls - Aspen Biopharma Labs Pvt., Ltd.
Wed Mar 19 2025
1 of 1
Summary
CGMP violations
Product Description
| Drug | Manufacturer | Distribution Pattern | Number of Affected Units |
|---|---|---|---|
| Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping. | Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida) | 400.0 gm | |
| Chlorambucil Container Description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping. | Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida) | 5.1 kg | |
| Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping. | Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida) | 120.0 kg | |
| Alprostadil Container Description: Amber color bottle | Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida) | 3.0 gm | |
| Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle | Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida) | 150.0 gm | |
| Voriconazole Container Description: voriconazole The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping. | Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida) | 4.0 kg |